NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.
Vaccine strategies that target dendritic cells to elicit potent cellular immunity are the subject of intense research. Here we report that the genetically engineered yeast Saccharomyces cerevisiae, expressing the full-length tumour-associated antigen NY-ESO-1, is a versatile host for protein product...
Main Authors: | Wadle, A, Mischo, A, Strahl, S, Nishikawa, H, Held, G, Neumann, F, Wullner, B, Fischer, E, Kleber, S, Karbach, J, Jager, E, Shiku, H, Odunsi, K, Shrikant, P, Knuth, A, Cerundolo, V, Renner, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
by: Jäger, E, et al.
Published: (2000) -
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
by: Chen, J, et al.
Published: (2000) -
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
by: Chen, J, et al.
Published: (2015) -
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
by: Gnjatic, S, et al.
Published: (2000) -
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.
by: Purbhoo, M, et al.
Published: (2006)